RealPharma: Conversations with Pharma Pathfinders
by RealPharma
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 6 chart positions in 6 markets.
By chart position
- 🇩🇪DE · Life Sciences#7530K to 100K
- 🇺🇸US · Life Sciences#1235K to 30K
- 🇪🇸ES · Life Sciences#1121K to 10K
- 🇸🇬SG · Life Sciences#123500 to 3K
- 🇹🇼TW · Life Sciences#186500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
19K to 75K🎙 ~2x weekly·57 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
38K to 149K🇩🇪67%🇺🇸20%🇪🇸7%+3 more - Active Followers
Loyal subscribers who consistently listen
11K to 45K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 11 epsHosts
Recent guests
Recent episodes
Good Intentions, Bad Outcomes: Rethinking Healthcare Policy with Deborah Williams
Jul 10, 2026
58m 53s
The New Biopharma Talent Market: AI, M&A, and a K-Shaped Recovery
Apr 20, 2026
53m 56s
What Farmers Know About Cancer with Chris Gregg
Mar 30, 2026
58m 24s
The Opioid Reckoning (Part 2): Paul Farrell Jr.
Mar 10, 2026
52m 57s
The Opioid Reckoning (Part 1): Paul Farrell Jr.
Mar 2, 2026
1h 03m 33s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/10/26 | healthcare policyunintended consequences+4 | Deborah Williams | U.S. healthcare system340B Drug Pricing Program+4 | — | healthcare policy340B+6 | — | 58m 53s | ||
| 4/20/26 | biopharma talent marketAI in recruiting+5 | Kristiaan Rawlings | EPM Scientific | — | biopharmatalent market+5 | — | 53m 56s | ||
| 3/30/26 | cancer careadaptive therapy+4 | Dr. Christopher Gregg | Storyline HealthPrimordial AI+1 | — | canceroncology+5 | — | 58m 24s | ||
| 3/10/26 | opioid crisislitigation+3 | Paul T. Farrell Jr. | PBSThe Bitter Pill | Huntington, West Virginia | opioid litigationpublic health accountability+3 | — | 52m 57s | ||
| 3/2/26 | opioid crisislitigation+4 | Paul Farrell Jr. | pharmaceutical supply chain | West VirginiaHuntington, West Virginia | opioid crisislitigation+5 | — | 1h 03m 33s | ||
| 2/17/26 | rare diseasehealthcare reform+3 | Joshua Resnikoff | Sunstone HealthHarvard’s Wyss Institute | — | rare diseasehealthcare spending+3 | — | 58m 11s | ||
| 1/26/26 | empathy in healthcarepatient advocacy+3 | Matthew Zachary | Stupid Cancer | — | empathyhealthcare+5 | — | 59m 11s | ||
| 1/12/26 | pharmaceutical communicationdrug pricing+3 | Brian Reid | Reid Strategic | — | pharmacommunication+3 | — | 52m 54s | ||
| 12/15/25 | CDMOsdrug formulation+4 | Elizabeth Hickman | Austin Pharmaceutics | — | CDMOdrug development+6 | — | 45m 54s | ||
| 12/8/25 | Inflation Reduction ActMedicare Drug Price Negotiation+4 | Emma CousinAmos Fung | Choice Institute – UWRealPharma+1 | — | Inflation Reduction ActMedicare+5 | — | 46m 48s | ||
| 11/24/25 | cell therapyacoustic-powered gene delivery+3 | Dr. Andrew Gray | CellEchoBMS+1 | — | cell therapygene delivery+5 | — | 51m 41s |
Showing 11 of 11
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Similar Audience Demographics
Podcasts that attract a similar listener profile
Chart history for RealPharma: Conversations with Pharma Pathfinders
Peaked at #75 in Germany, currently #75 in Germany.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| Germany | — | #75 | #75 | — |
| Spain | — | #112 | #112 | — |
| United States | — | #123 | #123 | — |
| SG | — | #123 | #123 | — |
| TW | — | #186 | #186 | — |
| BE | — | #195 | #195 | — |
Chart Positions
6 placements across 6 markets.
Chart Positions
6 placements across 6 markets.